药物对比
Bexagliflozin vs Rosiglitazone
Bexagliflozin 与 Rosiglitazone 治疗2型糖尿病的比较：SGLT2抑制剂 vs TZD，涵盖疗效、体重、心力衰竭风险等内容。
此页面暂无可用的对比维度。
临床背景
This comparison is triggered for type 2 diabetes patients evaluating SGLT2 inhibitors against older TZDs amid cardiovascular or weight concerns.
结论
Bexagliflozin often provides a preferable profile with extra benefits over Rosiglitazone, though neither suits every patient equally.
全部药物对比